FDA updates draft guidance on race and ethnicity reporting in clinical trials
The FDA published draft guidance on Monday directing clinical trial sponsors to include race and ethnicity information on their proposed product …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
